Sort
48,018 grants matching “immunotherapy”
Lineage heterogeneity and plasticity in lung cancer
$498,257Hideo Watanabe · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$498,243Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$498,235Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2023 · CA
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$498,233Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2022 · CA
Tissue engineering tools for monitoring the cellular and molecular response to therapy
$498,230Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Multiscale data geometric networks for learning representations and dynamics of biological systems
$498,229Smita Krishnaswamy · Yale University · · FY2023 · MPS
INSIDE-OUT IMMUNOTHERAPY: PREVENTING METASTATIC BREAST CANCER RECURRENCE VIA NANOPARTICLE-DIRECTED MODULATION OF THE TUMOR MICROENVIRONMENT
$498,227Vanderbilt University, The · · FY2016 · Department of the Army
Transfusion Biology and Medicine
$498,113Leslie Eric Silberstein · Boston Children'S Hospital · T32 · FY2009 · HL
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio
$498,100Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · HL
Overcoming stromal barriers to therapeutics in pancreas cancer
$497,999Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
UCLA Tumor Immunology Institutional Traning Grant
$497,990Michael A Teitell · University Of California Los Angeles · T32 · FY2018 · CA
Resource for Nonhuman Primate Immune Reagents
$497,967Francois J Villinger · Emory University · R24 · FY2012 · OD
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas
$497,964Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2023 · CA
Optimized ultrasound-enhanced immunotherapy
$497,935Katherine W Ferrara · University Of California At Davis · R01 · FY2017 · CA
DKK2 regulates NK activation and tumor immunity
$497,913Dianqing Wu · Yale University · R01 · FY2019 · CA
Regulators of Cancer Immunotherapy Response
$497,881Xiaole Shirley Liu · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules
$497,777Trachette Jackson · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
$497,774Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Metabolic Impacts of Type II Interferon Signals in Obesity
$497,758Sean Hartig · Baylor College Of Medicine · R01 · FY2025 · DK
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas
$497,714Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2021 · CA
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
$497,648Weizhou Zhang · University Of Florida · R01 · FY2023 · CA
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$497,607Darell D Bigner · Duke University · P01 · FY2021 · CA
Role of Neutralizing Antibodies in Transmission of SHIV
$497,587Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2009 · HD
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$497,523Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA
Molecular mechanisms and therapeutic targeting of PI3K-p110beta/PTEN signaling in breast cancer and cancer immunity
$497,522Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2019 · CA